Onyx Biotec Limited Financial Ratios
ONYX · Healthcare · Current price ₹37.25
P/E ratio
-322.9x
P/B ratio
1.3x
ROE
-0.4%
ROCE
1.1%
Debt / Equity
0.27
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | -322.9x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 1.3x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | -0.4% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 1.1% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.27 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Onyx Biotec Limited's latest numbers.
Onyx Biotec Limited profitability
Onyx Biotec Limited generates a return on equity of -0.4% and a return on capital employed of 1.1%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.27 and a P/E of -322.9x, Onyx Biotec Limited is conservatively financed. Our overall business-quality score for the company is 4.7 / 10.
Understand the ratios
More on Onyx Biotec Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.